This Million Position Signals Conviction in Biotech Stock
When a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
Review year-by-year annual performance for index funds to uncover patterns that inform proactive asset allocation.
25,727 articlesWhen a big investor deploys tens of millions into a biotech name ahead of an FDA decision, it can signal strong convi...
As the Dow breaks above 50,000 in early 2026, investors revisit the ghost 36,000 milestone and debate whether old bet...
Palantir stock plunging today is drawing attention from traders and long-term investors alike. This article breaks do...
Today's market action centers on semiconductor chatter, a solid Micron after-hours surge, and a mixed read across maj...
When inflation data softens, it can spark a rush into riskier assets like crypto. But a cooler print alone isn’t a gr...
Turn a few pages into a powerful investing habit. This guide shows how to structure your Thursday reads routine, pick...
Oil prices surged to a peak near $119 before pulling back, creating a volatile week for markets. Here are three takea...
Tensions with Iran are driving a puzzling market mix: gold retreats while equities slip only modestly, hinting at a b...
Dow futures slid while oil prices rose as Iran’s stalemate keeps a risk premium in play. Markets brace for inflation ...
Tech stocks swung wildly midday as traders dumped riskier names, then rotated into consumer staples and paints. By da...
As Bitcoin sits in the current price range, analysts lay out a spectrum of 2030 outcomes. This story unpacking scenar...
Wall Street watches a hypothetical shift as chair kevin warsh just signals a new, discipline-focused approach at the ...